Cargando…
Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
BACKGROUND: Triple negative breast cancer (TNBC) is an aggressive neoplasia with no effective therapy. Our laboratory has developed a unique TNBC cell model presenting epithelial mesenchymal transition (EMT) a process known to be important for tumor progression and metastasis. There is increasing ev...
Autores principales: | Su, Yanrong, Hopfinger, Nathan R., Nguyen, Theresa D., Pogash, Thomas J., Santucci-Pereira, Julia, Russo, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295063/ https://www.ncbi.nlm.nih.gov/pubmed/30547810 http://dx.doi.org/10.1186/s13046-018-0988-8 |
Ejemplares similares
-
Epigenetic reprogramming in the epithelial-to-mesenchymal transition
por: Hoang, Stephen, et al.
Publicado: (2012) -
Histone Methyltransferase SETD1A Induces Epithelial-Mesenchymal Transition to Promote Invasion and Metastasis Through Epigenetic Reprogramming of Snail in Gastric Cancer
por: Wu, Jugang, et al.
Publicado: (2021) -
Development and characterization of two human triple‐negative breast cancer cell lines with highly tumorigenic and metastatic capabilities
por: Su, Yanrong, et al.
Publicado: (2016) -
The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition of lens epithelial cells
por: Chen, X, et al.
Publicado: (2013) -
Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
por: Kong, Dejuan, et al.
Publicado: (2012)